PlainRecalls
FDA Drug Moderate Class II Terminated

TESTOSTERONE CYPIONATE/ ANASTROZOLE *GS* OIL (10ML) 200MG/0.5MG/ML; Packaged in a multi dose 10ML vial, as a) (CA) 4 ML Formula ID 136164; b) (RM) 10 ML Formula ID 115962; APS Phar

Reported: April 6, 2022 Initiated: March 23, 2022 #D-0731-2022

Product Description

TESTOSTERONE CYPIONATE/ ANASTROZOLE *GS* OIL (10ML) 200MG/0.5MG/ML; Packaged in a multi dose 10ML vial, as a) (CA) 4 ML Formula ID 136164; b) (RM) 10 ML Formula ID 115962; APS Phar

Reason for Recall

Lack of sterility assurance.

Details

Units Affected
73 vials
Distribution
Nationwide in the USA including Puerto Rico.
Location
Palm Harbor, FL

Frequently Asked Questions

What product was recalled?
TESTOSTERONE CYPIONATE/ ANASTROZOLE *GS* OIL (10ML) 200MG/0.5MG/ML; Packaged in a multi dose 10ML vial, as a) (CA) 4 ML Formula ID 136164; b) (RM) 10 ML Formula ID 115962; APS Phar. Recalled by Drug Depot, Inc., dba APS Pharmacy. Units affected: 73 vials.
Why was this product recalled?
Lack of sterility assurance.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 6, 2022. Severity: Moderate. Recall number: D-0731-2022.